Literature DB >> 17602194

Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model.

Li Li1, Christi M Terry, Donald K Blumenthal, Tadashi Kuji, Takahisa Masaki, Bonnie C H Kwan, Ilya Zhuplatov, John K Leypoldt, Alfred K Cheung.   

Abstract

BACKGROUND: Implantation of a haemodialysis arteriovenous graft is often followed by the development of neointimal hyperplasia (NH) at the venous anastomosis. The nature of the proliferating cells in these lesions is not well understood. A better understanding of the cells contributing to NH is important to the development of preventive strategies.
METHODS: Carotid-jugular PTFE grafts were placed in 21 pigs and characterized at various time points following implantation. Venous anastomotic tissues were harvested at 1, 7, 14, 21, 28 or 49 post-operative days for histology and immunohistochemistry.
RESULTS: Van Gieson staining of the tissues showed that NH was apparent as early as day 7 and progressed over time. Even by day 1, there were cells expressing the proliferation marker Ki-67 in the venous adventitia, but not the media, at the anastomosis. Double immunohistochemical staining showed that these cells were positive for alpha-smooth muscle actin (alpha-SMA), but negative for smooth muscle myosin heavy chain (SM MHC), suggesting that the proliferating cells were myofibroblasts rather than smooth muscle cells. By day 7, proliferating cells were abundant in the adventitia and began to appear in the media, surrounded by extracellular matrix visualized using Trichrome staining. By day 49, alpha-SMA-positive, SM MHC-negative cells were predominant in the NH, and Ki-67 staining had largely vanished.
CONCLUSIONS: These results are consistent with the hypothesis that adventitial fibroblasts are transformed into myofibroblasts and begin to proliferate within hours after graft placement. Migration of these cells towards the vessel lumen with subsequent proliferation appears to be a major contributor to NH formation. The pivotal role of the adventitial fibroblasts in the pathogenesis of NH provides a compelling rationale for therapies that target the transformation, proliferation and migration of these cells to prevent arteriovenous graft stenosis.

Entities:  

Mesh:

Year:  2007        PMID: 17602194     DOI: 10.1093/ndt/gfm415

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  35 in total

1.  Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: implications for venous neointimal hyperplasia in hemodialysis access.

Authors:  Sanjay Misra; Alex A Fu; Khamal D Misra; Uday M Shergill; Edward B Leof; Debabrata Mukhopadhyay
Journal:  J Vasc Interv Radiol       Date:  2010-06       Impact factor: 3.464

2.  Prevention of Venous Neointimal Hyperplasia by a Multitarget Receptor Tyrosine Kinase Inhibitor.

Authors:  Sun Hyung Kwon; Li Li; Yuxia He; Chieh Sheng Tey; Huan Li; Ilya Zhuplatov; Seung-Jung Kim; Christi M Terry; Donald K Blumenthal; Yan-Ting Shiu; Alfred K Cheung
Journal:  J Vasc Res       Date:  2016-01-21       Impact factor: 1.934

Review 3.  Novel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway?

Authors:  Timmy Lee
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

4.  Differential gene expression patterns in vein regions susceptible versus resistant to neointimal hyperplasia.

Authors:  Sun Hyung Kwon; Li Li; Christi M Terry; Yan-Ting Shiu; Philip J Moos; Brett A Milash; Alfred K Cheung; Donald K Blumenthal
Journal:  Physiol Genomics       Date:  2018-05-11       Impact factor: 3.107

Review 5.  New Insights into Dialysis Vascular Access: Molecular Targets in Arteriovenous Fistula and Arteriovenous Graft Failure and Their Potential to Improve Vascular Access Outcomes.

Authors:  Timmy Lee; Sanjay Misra
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

6.  Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.

Authors:  William G Sanders; Christophe Morisseau; Bruce D Hammock; Alfred K Cheung; Christi M Terry
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

7.  Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

Authors:  William G Sanders; Huan Li; Ilya Zhuplatov; Yuxia He; Seong-Eun Kim; Alfred K Cheung; Jayant Agarwal; Christi M Terry
Journal:  J Control Release       Date:  2017-09-01       Impact factor: 9.776

Review 8.  Neointimal hyperplasia associated with synthetic hemodialysis grafts.

Authors:  Li Li; Christi M Terry; Yan-Ting E Shiu; Alfred K Cheung
Journal:  Kidney Int       Date:  2008-07-30       Impact factor: 10.612

9.  Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis.

Authors:  Simona Simone; Antonia Loverre; Marica Cariello; Chiara Divella; Giuseppe Castellano; Loreto Gesualdo; Giovanni Pertosa; Giuseppe Grandaliano
Journal:  J Nephrol       Date:  2014-02-27       Impact factor: 3.902

Review 10.  Novel therapies for hemodialysis vascular access dysfunction: myth or reality?

Authors:  Christi M Terry; Laura M Dember
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.